Sabrina Spencer, University of Colorado (IMAGE) University of Colorado Anschutz Medical Campus Caption Sabrina Spencer, PhD and colleagues show that reactivation of the MAPK signaling pathway may allow melanoma to survive long enough to evolve treatment resistance Credit University of Colorado Cancer Center Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.